A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to winterize the castle, catch up on some reading, and hang with our short person. And what about you? This is a good time to plan a holiday break. You could bolster the economy and shop for wintry sweaters. Or perhaps you might enjoy calculating the impact the tax bill will have on your future. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Philippines government plans to sue Sanofi (SNY) and seek a $59 million refund over its dengue fever vaccine in response to a warning the drug could lead to severe infections in some cases, ABS-CBN News tells us. On Monday, regulators suspended use of Dengvaxia after Sanofi said it could worsen symptoms of dengue fever among people who were not infected by the virus before vaccination. Roughly 730,000 schoolchildren have been vaccinated.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Kudos to Pfizer for choosing to manufacture skins in a country with one of the highest rates of HIV/AIDS in the world.

    Good thinking.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.